Navigation Links
Neurobiological Technologies, Inc. Reports First Quarter Fiscal Year 2009 Financial Results
Date:11/6/2008

- FINANCIAL TABLES TO FOLLOW -

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(in thousands, except per share data)

Three months ended

September 30,

2008 2007

REVENUES

Royalty $2,078 $1,981

Technology sale and collaboration services 1,487 1,919

Total revenues 3,565 3,900

EXPENSES

Research and development 5,452 5,460

General and administrative 1,331 1,659

Total expenses 6,783 7,119

Operating loss (3,218) (3,219)

Interest income 249 28

Gain on sale of long-term investments 170 --

Interest expense, including non-cash

amortization of $588 discount on

notes for the three months ended

September 30, 2007 -- (633)

Non-cash gain on decrease in fair

value of warrants 37 2,902

NET LOSS $(2,762) $(922)

BASIC AND DILUTED NET LOSS PER SHARE $(0.10) $(0.19)

Shares used in basic and diluted net loss

per share calculation 26,924 4,772

SELECTED CONSOLIDATED BALANCE SHEET DATA

(in thousands)

September 30, June 30,


'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Neurobiological Technologies to Present at the Rodman & Renshaw 10th Annual Healthcare Conference in New York on November 10
2. Neurobiological Technologies Sets Date for First Quarter Financial Results
3. Neurobiological Technologies Reports Receipt of $2 Million Royalty Payment for Quarterly Sales of Memantine
4. Neurobiological Technologies to Present at the BIO Investor Forum in San Francisco on October 30, 2008
5. Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program
6. Neurobiological Technologies, Inc. (Nasdaq: NTII) Q4/08 Review Issued by Scimitar Equity, LLC
7. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
8. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
9. Neurobiological Technologies CEO to Retire on December 31, 2008
10. Neurobiological Technologies Reports Third Quarter Financial Results
11. Neurobiological Technologies Sets Date for Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich Corporation ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements ... expired on December 22, 2014, thereby completing the ... for the acquisition of the Company by Merck ... clearance satisfies another condition to closing the transaction, ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 /PRNewswire/ ... study of mazindol in children with attention deficit/hyperactivity disorder ... December 2014 . The paper, titled ... attention deficit/hyperactivity disorder" ( Konofal et al, ... eCollection 2014 ) shows that mazindol might be ...
(Date:12/22/2014)... 22, 2014   Synthetic Biologics, Inc. ... pathogen-specific therapies for serious infections and diseases, ... today announced positive topline safety and tolerability ... of SYN-004, the Company,s investigational oral beta-lactamase ... difficile (C. difficile) infection, antibiotic-associated diarrhea ...
(Date:12/22/2014)... 22, 2014  Alternative Energy & Environmental Solutions, ... signed a letter of intent to acquire BioTechPharma ... patented a nanotechnology-based development platform used to create ... rapid on-site collection and testing to identify infectious ... in an immediate, non-invasive and cost-effective manner. ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5ALNE Announces Intention To Acquire BioTechPharma 2
... Biosciences, Inc., a biotechnology company developing pharmaceutical products ... million dollar financing deal. The majority of the ... and the remainder was borrowed from the Madison ... Lease Funds, a private investment firm. The funds ...
... strange: the person touting it just might be the ... experienced entrepreneurs speaking to attendees at the first Wisconsin ... looks and whispers their entire working lives, and they ... whispers as a way of life and help each ...
... capital financier with a portfolio perspective knows that many ... generate high returns to make up for the losers. ... return requirement, the winners will have to return 10-20 ... $500,000+). Using some basic assumptions (7.5% ROS, 10x P/E), ...
Cached Biology Technology:Quintessence Secures Financing 2Quintessence Secures Financing 3Lowering the fear factor for entrepreneurs, intra-preneurs 2Lowering the fear factor for entrepreneurs, intra-preneurs 3Growth: the Good, the Bad, and the Ugly 2Growth: the Good, the Bad, and the Ugly 3Growth: the Good, the Bad, and the Ugly 4
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, ... licensed its PerformTek biometric technology to industry leaders such ... highly accurate, clinically validated, biometric wearable products. These products ... 6-9 in Las Vegas . ... technology is accurate, flexible and robust – with the ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally ... more evident than at international borders. Over the ... scanners have allowed veteran travelers to self process ... Control (APC) Kiosks at an increasing number of ... According to Maxine Most ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... classifying foods as "whole grain" are inconsistent and, in ... Harvard School of Public Health (HSPH) researchers. One of ... Stamp, actually identified grain products that were higher in ... The researchers urge adoption of a consistent, evidence-based standard ...
... New Rochelle, NY, January 10, 2013Stem cells can be ... as bone, cartilage, and muscle for repair and regeneration ... the cells must often grow in a specific pattern ... polymer scaffold that can support complex tissue architectures is ...
... most difficult problems in the field of genomics is ... In a new paper published in Proceedings of ... of genome and computer scientists has solved this problem, ... with no prior information about how the genome is ...
Cached Biology News:Foods identified as 'whole grain' not always healthy 2Foods identified as 'whole grain' not always healthy 3Solving puzzles without a picture 2
...
... The Agilent 6850 Networked GC is an ... the footprint of a standard dual-channel GC, this ... two GCs in the space of one. You ... for routine GC analyses in an instrument that ...
... GC-8A is Shimadzu's basic gas chromatograph model ... use, the GC-8A supports a single detector, ... injection port(s), and analog output. Isothermal or ... The GC-8A is only 17.3 inches (43.9 ...
... laboratory animal infusion kits reduce the time ... study while providing sterile equipment to reduce ... everything you need for one animal, including ... tethers will be cut to the exact ...
Biology Products: